Generics 13

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Lacosamide manufacturers

13 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

13 products found

lacosamide

Tablets 50 mg, 100 mg, 150 mg, 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Registered in
Spain
MAs for sale
Spain
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 9 days

lacosamide

Tablets 50 mg, 100 mg, 150 mg, 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #10627

Manufacturer usually replies in 9 days

lacosamide

Oral solution 10 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Australia , New Zealand
Comments
DCP procedure
Manufacturer #10627

Manufacturer usually replies in 9 days

lacosamide

Tablets 50 mg, 100 mg, 150 mg , 200 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #21496

It's a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 9 days

lacosamide

Tablets 50 mg, 100 mg, 150 mg, 200 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #17643

Manufacturer usually replies in 8 days

lacosamide

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20162

Manufacturer usually replies in 3 days

lacosamide

Syrup 15mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
Canada, FDA, WHO
Manufacturer #16400

Manufacturer usually replies in 8 days

lacosamide

Tablets 50 mg, 100 mg, 150 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 7 days

lacosamide

Vials, injection 10 mg/ml - 20 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA, TGA, WHO
Manufacturer #12792

Manufacturer usually replies in 6 days

lacosamide

Tablets, film coated 50 mg, 100 mg, 150 mg, 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Panama
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

lacosamide

Tablets 50 mg, 100 mg, 150 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, EU GMP
Manufacturer #20273

Manufacturer usually replies in 21 days

lacosamide

Tablets 50,100,150,200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
TGA
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #17731

Manufacturer usually replies in 20 days

lacosamide

Tablets 100 mg, 150 gm, 200 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #31070

Manufacturer usually replies in nan days

Lacosamide

Lacosamide is a medication used in the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. It is used alone and in combination with other medications to control certain types of seizures in adults and children 4 years of age and older to prevent and control seizures. Lacosamide is in a class of medications called anticonvulsants or antiepileptic drugs. It works by reducing the spread of seizure activity in the brain by decreasing abnormal electrical activity in the brain. Lacosamide is the prescribed in the treatment of Temporal Lobe Epilepsy, Focal Impaired Awareness or Complex Partial Seizures, Secondarily Generalized Seizures or Bilateral Tonic-Clonic Seizure, Focal Aware or Simple Partial Seizure.
Lacosamide the generic name for the brand drug called Vimpat. Schwarz Pharma got FDA approval for clinical use in 2008. UCB Pharma acquired Schwarz Pharma in 2007, and following its approval, Lacosamide has been marketed by UCB Pharma or its partners.

Dosage and forms:

Lacosamide is available in multiple formulations including oral tablets, syrup, and intravenous (IV) infusion. When used with other seizure medicines in adults, Lacosamide usual initial recommended dose starts at 100 mg daily and in some cases, the patients may be started on 200 mg daily and increased weekly. Amongst children, the usual recommended dose for kids between 11 kg and less than 30 kg is 6 mg to 12 mg per kilogram of body weight each day. For kids who weigh between 30 kg and less than 50 kg, the usual standard dose is 4 mg to 8 mg per kilogram of body weight each day. And for kids who weigh more than 50 kg and higher, the usual initial dose is 50 mg, taken twice a day and can be increased as per the Doctor’s discretion.

The cost of Lacosamide:

As of 2020, the consumer has to pay around $823 Vimpat intravenous solution for a supply of 200 mg/20 mL, for a supply of 200 milliliters and 60 tablets of 100mg costs $1054. However, the costs of this medicine are significantly lower in the developing world. In India, the same supply for 60 tablets of 100mg sells for as low as $15.

How does it work?

Brain cells work and talk to each other through electrical discharges. These discharges must fire at a certain frequency to function normally. Sodium channels are like gates of brain cells, as in, they carry electrical activity from one cell to another. Lacosamide actions slow down these electrical discharges in some way or the other. Because its action either turns off or slows down the sodium channels in the brain. Thus the patient finds relief from the seizure and allows the brain cells to recover.

Finding Lacosamide Manufacturers and Suppliers:

The process of finding trusted Lacosamide manufacturers and Lacosamide suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities.
The robust search engine makes it convenient to search for manufacturers and suppliers of Lacosamide. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.